GlizzyGobbler
Set a live reminder
Join us for an exclusive webinar hosted by Cboe Options Institute, featuring Nishank Modi, Sr. Director, Cboe Labsand OI Adjunct Faculty Member, as we share/explore a Beginner's Guide to Options Trading Strategies.
In this complimentary session from moomoo, you'll uncover:
Reasons for using options and commonly used options strategies
How a covered call strategy works and its benefits and risks
Features of a cash-secured put strategy and a com...
In this complimentary session from moomoo, you'll uncover:
Reasons for using options and commonly used options strategies
How a covered call strategy works and its benefits and risks
Features of a cash-secured put strategy and a com...
2
1
GlizzyGobbler
liked
1. Don’t trust someone who only shares a paper portfolio instead of a real portfolio.
- Paper portfolios are simulations that lack real capital, meaning they don't reflect the psychological pressures and market dynamics of actual trading. This can be misleading as it may only pretend to demonstrate an investor's skill and decision-making in real market scenarios, not their true ability to handle real investments.
2. Don’t trust investors or traders who manage l...
- Paper portfolios are simulations that lack real capital, meaning they don't reflect the psychological pressures and market dynamics of actual trading. This can be misleading as it may only pretend to demonstrate an investor's skill and decision-making in real market scenarios, not their true ability to handle real investments.
2. Don’t trust investors or traders who manage l...
27
4
GlizzyGobbler
liked
Towards a better passive income, here is my report card for the month of April. Can't say it is remarkable but at least it is a good start for myself. Gambaro
10
1
GlizzyGobbler
liked and commented on
GlizzyGobbler
liked
$Kazia Therapeutics(KZIA.US$ SYDNEY, May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team (SRT) of the EVT801 Phase 1 clinical trial has concluded that the primary and secondary objectives of stage 1 of the trial have successfully been met. It shoulda been a weight loss drug making good advancement! It would be climbing then! Hehehe
3
9